Stanford University Licenses IPA, Collaborates on Systems Biology Solutions

STANFORD GENOME TECHNOLOGY CENTER WILL APPLY INGENUITY’S TECHNOLOGY TO MORE QUICKLY AND COMPREHENSIVELY UNDERSTAND THE BIOLOGY UNDERLYING THEIR EXPERIMENTAL DATASETS

Mountain View, California, Nov 3, 2003 – Ingenuity is pleased to announce today that the Stanford Genome Technology Center at Stanford University has licensed IPA, a new web-delivered application that enables biologists to discover, visualize, and explore therapeutically relevant networks significant to their experimental results.

Dr. Ronald Davis, Professor of Biochemistry and Genetics at Stanford University and Director of the Stanford Genome Technology Center, first used the application during its beta release. Dr. Davis, who is pleased with the application’s novel analysis of gene expression data said, “IPA is the first successful application to bring a systems biology approach to large datasets, enabling functional analysis on a genome scale. Its delivery, incredible ease-of-use, and most importantly, its biological insights, make this a necessary solution for anyone doing gene or protein based research.”

In addition to licensing the IPA application, Ingenuity and the Stanford Genome Technology Center are collaborating on the development of new functionality to further extend the application’s capabilities and the state of the art of systems biology.

Jake Leschly, President and CEO of Ingenuity Systems stated, “We are pleased to be working with Dr. Davis and his team. Together, we will advance the field of systems biology and its practical application to everyday research challenges.”

About Ingenuity Systems

Ingenuity Systems is helping life science researchers explore and understand biological systems that are foundational to human health and disease. Ingenuity delivers capabilities and expertise to researchers through analysis software, genome-scale computable network databases, and knowledge management services and infrastructure, resulting in increased productivity and faster drugs to market. The company was founded in 1998 and is headquartered in Mountain View, California.www.ingenuity.com.

About Stanford Genome Technology Center

The Stanford Genome Technology Center is one of the National Institute of Health (NIH) genome centers funded since 1993 by the National Human Genome Research Institute (NHGRI). Dr. Ronald W. Davis, Professor of Biochemistry and Genetics, is the director of the center. The Stanford Genome Technology Center is located just south of the Stanford University Campus at 855 California Avenue, Palo Alto, CA 94304.